Contribution of positron emission tomography for the management of lung cancer;Interet de la tomographie a emission de positons dans la prise en charge du cancer broncho-pulmonaire

Revue de Pneumologie Clinique

Volumn 56, Issue 2, 2000, Pages 125-131

  Bury, Th ^a   Rigo, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

18FDG PET; Lung cancer; Pulmonary nodule

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG CANCER; LUNG NODULE; LUNG SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; BRONCHUS TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; REVIEW; SCINTISCANNING;

BRONCHIAL NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034128440     PISSN: 00325821     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Quint L.E., Francis I.R., Wahl R.L., Gross B.H., Glazer G.M. : Preoperative staging of non-small cell carcinoma of the lung : imaging methods. Am. J. Roentgenol., 1995, 164, 1349-59.
2. Kazerooni E.A., Lim F.T., Mikhail A., Martinez F J. : Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology, 1996, 198, 371-5.
3. Al-Sugair A., Coleman E. : Applications of PET in lung cancer. Sem. Nucl. Med., 1998, 28, 303-19.
4. Warburg O. : The metabolism of tumors In Smith RR Inc, New York 1931 : p. 129-139
5. Midthun D., Swensen S., Pett J. : Clinical strategies for solitary pulmonary nodules. Ann. Rev. Med., 1992, 93, 195-208.
6. Bury T., Dowlati A., Paulus P., Corhay J.L., Benoit T., Kayembe J.M., Limet R., Rigo P., Radermecker M. : Evalution of the solitary pulmonary nodule by PET imaging. Eur. Resp. J., 1996, 9, 410-4.
7. Rigo P., Paulus P., Kaschten B.J., Hustinx R., Bury T., Jerusalem G., Benoit T., Foidart J. : Oncological applications of positron emission tomography with fluorine-18-fluorodeoxyglucose. Eur. J. Nucl. Med., 1996, 23, 1641-74.
8. Crisci R., Pavone P., Passariello R., Coloni G. : Bilan d'extension ganglionnaire médiastinal du cancer bronchique. Rev. Mal. Resp., 1991, 8, 205-8.
9. Shields T. : The significance of ipsilateral mediastinal lymph node metastatic (N2 disease) in non-small cell carcinoma of the lung. Thorac. Cardiovasc. Surg., 1990, 99, 48-53.
10. Bury T., Paulus P., Dowlati A., Corhay J.L., Weber T., Ghaye B., Schoffers J., Limet R., Albert A., Rigo P., Radermecker M. : Staging of the mediastinum : value of positron emission tomography imaging in non-small cell lung cancer. Eur. Respir. J., 1996, 9, 2560-4.
11. Vansteenkiste J.F., Stroobandt S.G., Dupont P.J., De Leyn P.R., De Wever W.F., Verbeken E.K., Nuyts J.L., Maes F.P., Bogaert J.G. and the Leuven Lung Cancer Group : FDG-PET scan in potentially operable non-small cell lung cancer : do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases ? Eur. J. Nucl. Med., 1998, 25, 1495-501.
12. Bury T., Dowlati A., Paulus P., Corhay J.L., Hustinx R., Ghaye B., Radermecker P., Rigo P. : Wholde-body 18FDG-PET in the staging of non small cell lung cancer. Eur. Respir. J., 1997, 10, 2529-34.
13. Lewis P., Griffin S., Marsden P., Gee T., Nunan T., Malsey M., Dussek J. : Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet, 1994, 344, 1265-6.
14. Valk P.E., Pounds T.R., Hopkins D.M., Haseman M.K., Hofer G.A., Greeiss H.B., Myers R.W., Lutrin C.L. : Staging lung cancer by PET imaging. Ann. Thorac. Surg., 1995, 60, 1573-82.
15. Patz E.F., Lowe V.J., Hoffman J.M., Paine S.S., Harris L.K., Goodman P.C. : Persistent or recurrent bronchogenic carcinoma : detection with PET and 2-(F-18)-2-deoxy-D-glucose Radiology, 1994, 191, 379-82.
16. Inoue T., Kim E.E., Komaki R., Wong F., Bassa P., Wong W., Yang D., Endo K., Podoloff D. : Detecting recurrent of residual lung cancer with FDG-PET. J. Nucl. Med., 1995, 37, 788-93.